Summary Induction chemotherapy in fit de novo acute myeloid leukaemia (AML) patients has historically combined an anthracycline with standard‐dose cytarabine (‘7 + 3’) despite complete response (CR) rates of 50%–70%. In May 2023, our institution adopted the utilization of cladribine, cytarabine, idarubicin and venetoclax (CLIA‐VEN) for intensive ...
Benjamin J. Lee +11 more
wiley +1 more source
Ph-triazole as a therapeutic agent for pancreatic cancer: Synthesis, in silico, and in vitro evaluation. [PDF]
Zhang N +5 more
europepmc +1 more source
Covalent fluorescent probes for 2‐arachidonoylglycerol metabolic pathways
Abstract Covalent fluorescent probes have emerged as versatile chemical tools to visualise active enzymes in complex biological systems. When tailored for specific applications, ranging from activity‐based protein profiling for drug development to high spatiotemporal resolution imaging of enzymatic activities, these probes provide unique insights into ...
Nick D. F. Puijmbroeck +1 more
wiley +1 more source
Study of Structural, Vibrational, and Molecular Docking Properties of (1<i>S</i>,9a<i>R</i>)-1-({4-[4-(Benzyloxy)-3-methoxyphenyl]-1<i>H</i>-1,2,3-triazol-1-yl}methyl)octahydro-2<i>H</i>-quinolizine. [PDF]
Turdybekov D +8 more
europepmc +1 more source
A practical guide to molecular docking and homology modelling for medicinal chemists [PDF]
Levonis, Stephan M +3 more
core +1 more source
Synthesis and Herbicidal Activity of New 2-(1-Carbamoyl-1, 2, 4-triazol-3-ylsulfonyl) alkanoates
Tomoyuki YANO +4 more
openaire +2 more sources
Heteromeric cis‐prenyltransferases (CPT) are indispensable for dolichol synthesis and protein N‐glycosylation in most eukaryotes. The catalytic subunits are strongly conserved throughout evolution, in contrast to the evolutionarily variable accessory subunits. The POC1 protein from Paramecium tetraurelia is the smallest identified CPT‐accessory subunit
Agnieszka Onysk +8 more
wiley +1 more source
Design, synthesis, <i>in silico</i> studies, and antiproliferative activity of a novel series of thiazole/1,2,3-triazole hybrids as apoptosis inducers and multi-kinase inhibitors endowed with anti-breast cancer activity. [PDF]
Mohamed FAM +10 more
europepmc +1 more source

